The AngioVac system as a bail-out option in infective valve endocarditis.
暂无分享,去创建一个
[1] J. Gurley,et al. A novel approach to percutaneous removal of large tricuspid valve vegetations using suction filtration and veno‐venous bypass: A single center experience , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[2] S. Talebi,et al. Last resort: successful AngioVac of fungal tricuspid valve vegetation. , 2017, QJM : monthly journal of the Association of Physicians.
[3] Tesfaye Telila,et al. A novel approach in the management of right-sided endocarditis: percutaneous vegectomy using the AngioVac cannula. , 2017, Future cardiology.
[4] G. Makdisi,et al. A successful percutaneous mechanical vegetation debulking used as a bridge to surgery in acute tricuspid valve endocarditis. , 2016, Journal of thoracic disease.
[5] David Vlahov,et al. Prospective study of infective endocarditis among injection drug users. , 2002, The Journal of infectious diseases.
[6] J. Frontera,et al. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] M. Guglin,et al. Use of AngioVac for Removal of Tricuspid Valve Vegetation. , 2018, Journal of Heart Valve Disease.
[8] J. Zamorano,et al. 2015 ESC Guidelines for the management of infective endocarditis. , 2016, Revista española de cardiología.
[9] F. Pinto. The 2015 ESC Guidelines for the management of infective endocarditis. , 2015, European heart journal.